Press release

Royal DSM, a global science-based company active in Nutrition, Health and Sustainable Living, brings breakthrough innovations to Vitafoods Europe 2021, where it will present purpose-led solutions linked to immunity, gut and brain health and more. Taking center stage at the show are DSM’s innovative and sustainable nutrient premixes and market-ready solutions. Paired with a deep understanding of consumer needs and unmatched formulation and regulatory expertise, DSM delivers fully customizable science-backed blends with validated claims. As an end-to-end partner, it can co-innovate with agility and streamline manufacturing processes to bring products to market faster.

Available as a market-ready solution, DSM’s algal-derived omega-3 – life’s™OMEGA – can help attract a new generation of consumers seeking more sustainable ways to achieve holistic health and wellbeing. life’s™OMEGA is the first and only commercially available plant-based omega-3 product that delivers the health benefits of both eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in a single, quality source. Well-known for supporting brain, eye and heart health, the extended benefits of life’s™OMEGA include its role in immunity, sports performance, mood and sleep.

With consumer interest in gut health on the rise, visitors to the booth can discover how DSM is helping brands leverage the benefits of HMOs in the dietary supplement space. DSM is pioneering innovation in the HMO market, thanks to its expertise in these gut-friendly nutrients. Demonstrating how it is taking gut health further still, DSM will also be previewing its latest solution, V-Direct. V-Direct is designed to help individuals optimize their health for a more resilient future. It utilizes unique coating technology to ensure a targeted release of a combination of C and B-group vitamins.

Immunity remains a top consumer health concern. At booth I40, DSM will present its broad portfolio of solutions for the maintenance of a normal immune system including an upcoming addition, ampli-D®. Earlier this year, DSM received a positive EFSA opinion for the Novel Food assessment of calcidiol, also known as calcifediol, that recognized the more efficient absorption of calcidiol compared to regular vitamin D3. Once the European Commission gives its authorization, DSM will launch ampli-D® across Europe where it will open up opportunities to quicky tackle low vitamin D status.

To join DSM at Vitafoods Europe and discover insight-led nutrition solutions that are inspired by people and delivered by experts, book an in-person or virtual appointment here.